Drugs
-
FDA Webinar: New Draft Guidance on "FDA Guidance for Industry Webinar on Draft Guidance Vaginal Microbicides: Development for the Prevention of HIV Infection" - January 22, 2013
On Tuesday, January 22, 2013, FDA presented a webinar to discuss the new draft guidance for industry entitled, “FDA Guidance for Industry Webinar on Draft Guidance Vaginal Microbicides: Development for the Prevention of HIV Infection"
Presenters:
- Charu Mullick, M.D.
- Kimberly Struble, Pharm.D.
-
Related Information
Adobe Connect Link
View Presentation Here- Draft Guidance for Industry: Human Immunodeficiency Virus: Developing Vaginal Microbicides for HIV Prevention (PDF - 163KB)
Download Dr. Mullick's Slides Here - New Draft Guidance for Industry: Human Immunodeficiency Virus: Developing Vaginal Microbicides for HIV Prevention (PDF - 617KB)
Download Dr. Struble's Slides Here FR Notice
View Federal Register Notice HereVaginal Microbicides:Development for the Prevention of HIV Infection PDF (PDF - 520KB)
Draft GFIFDA Webinar: 60-Day Draft Guidance on Using an Endpoint to Support Accelerated Approval of Drugs to Treat Early-Stage Breast Cancer - June 28, 2012
View Previous Webinar Here
-
-
-
